Indication

Scalp psoriasis

Scalp psoriasis is a chronic, immune-mediated dermatologic manifestation of psoriasis that selectively affects the integumentary system of the scalp and often extends beyond the hairline to the forehead, retroauricular regions, and posterior neck. Read more about Scalp psoriasis

762 drugs 195 manufacturers

Advertisement

Drugs that treat it

Common Scalp psoriasis therapies.

Showing 586–594 of 762 drugs

HYDROCORTISONE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
WEEKS & LEO CO.

HYDROCORTISONE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
TARGET CORP

FLUOCINONIDE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
ENCUBE ETHICALS

HALCINONIDE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
ENCUBE ETHICALS
Filter & compare in the drug finder →Opens the drug finder with Scalp psoriasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Scalp psoriasis.

Scalp psoriasis is a chronic, immune-mediated dermatologic manifestation of psoriasis that selectively affects the integumentary system of the scalp and often extends beyond the hairline to the forehead, retroauricular regions, and posterior neck.

It can occur as an isolated condition or as part of generalized plaque psoriasis, driven pathophysiologically by dysregulated T-cell signaling and sustained proinflammatory cytokine cascades that accelerate epidermal keratinocyte proliferation.

Clinically, it is characterized by well-demarcated, erythematous or violaceous plaques covered with thick, silvery-white or micaceous scale, frequently accompanied by pruritus, burning, soreness, and shedding that can occasionally result in secondary, temporary telogen hair loss.

Personalize your experience

Follow Scalp psoriasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it